Sign Up Now to Download a Free Research Report on MYGN
Sign-Up to Get the Equity Report on this Company Plus Exclusive Access to Our Winning Newsletter Alerts
Myriad Genetics, Inc.
Myriad Genetics shares spiked 2.99 percent on more than double the average daily volume Tuesday to close at $34.10 a share. The company received major exposure after Angelina Jolie announced she has decided to undergo a double mastectomy. Jolie made the decision after the BRACAnalysis predictive test showed she carried the BRCA1 gene.
Going forward ... (see research report)









